These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 36077167)

  • 1. Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis.
    Saitakis G; Chwalisz BK
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [OPTIC NEURITIS - CLASSIFICATION, MANAGEMENT AND TREATMENT].
    Almer Z
    Harefuah; 2022 Oct; 161(10):645-651. PubMed ID: 36315205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on optic neuritis.
    Kraker JA; Chen JJ
    J Neurol; 2023 Oct; 270(10):5113-5126. PubMed ID: 37542657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Typical and atypical optic neuritis].
    Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
    Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment.
    Gospe SM; Chen JJ; Bhatti MT
    Eye (Lond); 2021 Mar; 35(3):753-768. PubMed ID: 33323985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment].
    Wildemann B; Horstmann S; Korporal-Kuhnke M; Viehöver A; Jarius S
    Klin Monbl Augenheilkd; 2020 Nov; 237(11):1290-1305. PubMed ID: 33202462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Treatment of Acute Optic Neuritis.
    Keyhanian K; Chwalisz BK
    Semin Ophthalmol; 2023 Aug; 38(6):511-514. PubMed ID: 37162276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis-A Review.
    Kaushik M; Burdon MA
    J Neuroophthalmol; 2021 Dec; 41(4):e786-e795. PubMed ID: 33870945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
    Caron-Cantin M; Cestari DM; Fortin E
    Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuro-ophthalmological manifestations of NMOSD and MOGAD-a comprehensive review.
    Moheb N; Chen JJ
    Eye (Lond); 2023 Aug; 37(12):2391-2398. PubMed ID: 36928226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
    Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
    Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
    Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
    Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Pediatric Optic Neuritis.
    Gise RA; Heidary G
    Curr Neurol Neurosci Rep; 2020 Mar; 20(3):4. PubMed ID: 32124097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on glial antibody-mediated optic neuritis.
    Song H; Zhou H; Wei S
    Jpn J Ophthalmol; 2022 Sep; 66(5):405-412. PubMed ID: 35895155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort.
    Dauby S; Dive D; Lutteri L; Andris C; Hansen I; Maquet P; Lommers E
    Acta Neurol Belg; 2022 Feb; 122(1):135-144. PubMed ID: 34097296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuritis in the era of biomarkers.
    Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
    Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic neuritis in Turkish children and adolescents: A multicenter retrospective study.
    Direk MÇ; Besen Ş; Öncel İ; Günbey C; Özdoğan O; Orgun LT; Sahin S; Cansu A; Yıldız N; Kanmaz S; Yılmaz S; Tekgül H; Türkdoğan D; Ünver O; Thomas GÖ; Başıbüyük S; Yılmaz D; Kurt AN; Gültutan P; Özsoy Ö; Yiş U; Kurul SH; Güngör S; Özgör B; Karadağ M; Dündar NO; Gençpınar P; Bildik O; Orak SA; Kabur ÇÇ; Kara B; Karaca Ö; Canpolat M; Gümüş H; Per H; Yılmaz Ü; Karaoğlu P; Ersoy Ö; Tosun A; Öztürk SB; Yüksel D; Atasoy E; Gücüyener K; Yıldırım M; Bektaş Ö; Çavuşoğlu D; Yarar Ç; Güngör O; Mert GG; Sarıgeçili E; Edizer S; Çetin İD; Aydın S; Diler B; Özdemir AA; Erol İ; Okuyaz Ç; Anlar B
    Mult Scler Relat Disord; 2024 Jan; 81():105149. PubMed ID: 38096730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.